ProCE Banner Activity

Guideline Updates in Nontuberculous Mycobacterial Lung Disease Management

Slideset Download
Read expert faculty member summaries of guideline updates in the diagnosis, monitoring, and treatment of patients with nontuberculous mycobacterial lung disease (NTM-LD).

Released: November 08, 2021

Expiration: November 07, 2022

Share

Faculty

Keira A. Cohen

Keira A. Cohen, MD

Assistant Professor of Medicine
Pulmonary and Critical Care Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

David E. Griffith

David E. Griffith, MD

Professor of Medicine
Division of Mycobacterial and Respiratory Infections
Department of Medicine
National Jewish Hospital
Denver, Colorado

Princy N. Kumar

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Insmed Incorporated

Partners

NTMIR

ProCE Banner

Program Director Disclosure

Program Director

Keira A. Cohen, MD

Assistant Professor of Medicine
Pulmonary and Critical Care Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

Keira A. Cohen, MD, has disclosed that she has received consulting fees from HillRom, Insmed, Inc., and Microbion; and fees for non-CME/CE services from Insmed, Inc.

Faculty Disclosure

Primary Author

David E. Griffith, MD

Professor of Medicine
Division of Mycobacterial and Respiratory Infections
Department of Medicine
National Jewish Hospital
Denver, Colorado

David E. Griffith, MD, has disclosed that he has received funds for research support from Insmed, Inc.; has received consulting fees from AN2 Therapeutics and Insmed, Inc.; and fees for non-CME/CE services from Insmed, Inc.

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Princy N. Kumar, MD, FIDSA, MACP, has disclosed that she has received funds for research support from Amgen, Gilead Sciences, GlaxoSmithKline, and Merck; has received consulting fees from Amgen, GlaxoSmithKline, and Merck; and has ownership interests in Gilead Sciences, Johnson & Johnson, Merck, and Pfizer.